Home › Castration-Resistant Prostatic Cancer › Maryland › Baltimore
Castration-Resistant Prostatic Cancer clinical trials in Baltimore, MD
3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- University of Maryland, Baltimore
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Medical Institutions, Baltimore
- and 1 more
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- Johns Hopkins University, Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RecruitingPhase 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- New York City, NY7 studies
- Seattle, WA6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- Queens, NY4 studies
- Mountain View, CA3 studies
- Minneapolis, MN3 studies
- San Francisco, CA3 studies
- St. Louis, MO3 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.